Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00647231 · ClinicalTrials.gov registry record · Phase 2
HKT-500-US12 In Adult Patients With OA Knee Pain
A Phase 2 study, sponsored by Hisamitsu Pharmaceutical Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT00647231 is a Phase 2 study that has completed, run by Hisamitsu Pharmaceutical Co.. The registered enrollment target is 300 participants.
The verdict
NCT00647231, a Phase 2 study, has completed, sponsored by Hisamitsu Pharmaceutical Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee
Interventions
- OTHER Placebo Patch
- DRUG HKT-500 Topical Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00647231
The ClinicalTrials.gov registry entry for NCT00647231 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hisamitsu Pharmaceutical Co., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT00647231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00647231 about?
NCT00647231 is a clinical study titled "HKT-500-US12 In Adult Patients With OA Knee Pain". The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee
What is the current status of trial NCT00647231?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2008-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00647231?
The interventions under investigation include: Placebo Patch (OTHER), HKT-500 Topical Patch (DRUG).
Who is sponsoring clinical trial NCT00647231?
This trial is sponsored by Hisamitsu Pharmaceutical Co., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.